Saluda Medical Announces $125M Equity Financing
Net proceeds from the financing will be used to operationalize and scale commercialization of the Evoke® Spinal Cord Simulation System (SCS) for chronic pain.
March 2, 2022
Saluda Medical Announces $125M Equity Financing
Net proceeds from the financing will be used to operationalize and scale commercialization of the Evoke® Spinal Cord Simulation System (SCS) for chronic pain.